A detailed history of Empowered Funds, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Empowered Funds, LLC holds 90,402 shares of FLGT stock, worth $1.82 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
90,402
Previous 85,846 5.31%
Holding current value
$1.82 Million
Previous $1.68 Million 16.57%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$19.6 - $25.06 $89,297 - $114,173
4,556 Added 5.31%
90,402 $1.96 Million
Q2 2024

Jul 30, 2024

SELL
$19.09 - $22.57 $445,197 - $526,354
-23,321 Reduced 21.36%
85,846 $1.68 Million
Q1 2024

May 06, 2024

BUY
$21.55 - $29.29 $371,715 - $505,223
17,249 Added 18.77%
109,167 $2.37 Million
Q3 2023

Nov 01, 2023

BUY
$26.74 - $40.81 $198,571 - $303,055
7,426 Added 8.79%
91,918 $2.46 Million
Q2 2023

Jul 27, 2023

BUY
$28.52 - $40.7 $2.41 Million - $3.44 Million
84,492 New
84,492 $3.13 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Empowered Funds, LLC Portfolio

Follow Empowered Funds, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.